CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 

Healthcare Sector

Major Pharmaceutical Preparations Industry  


Data by Company within Major Pharmaceutical Preparations Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Abeona Therapeutics Inc. $ 652 $ 1 $ -23 -
Abbott Laboratories $ 91,143 $ 23,607 $ 1,171 77,000
Arbutus Biopharma Corp $ 383 $ 2 $ -275 -
Acadia Pharmaceuticals Inc $ 4,595 $ 63 $ -338 -
Achillion Pharmaceuticals Inc $ 561 - $ -66 -
Acelrx Pharmaceuticals Inc $ 145 $ 16 $ -50 -
Acura Pharmaceuticals, Inc $ 5 $ 7 $ -2 -
Alcobra Ltd. - - $ 0 -
Adamis Pharmaceuticals Corp $ 136 $ 11 $ -18 -
Adamas Pharmaceuticals Inc $ 477 - $ -66 -
Aduro Biotech, Inc. $ 782 $ 17 $ -106 -
Advaxis, Inc. $ 192 $ 14 $ -92 -
Aegerion Pharmaceuticals, Inc. - - $ 0 -
Agios Pharmaceuticals Inc $ 3,138 $ 53 $ -269 -
Aeglea Biotherapeutics, Inc. $ 67 $ 5 $ -25 -
Agile Therapeutics Inc $ 109 - $ -28 -
Aimmune Therapeutics, Inc. $ 1,200 - $ -106 -
Achaogen Inc $ 615 $ 34 $ -89 -
Akebia Therapeutics, Inc. $ 715 - $ -140 -
Akorn Inc $ 4,149 $ 1,020 $ 124 -
Albireo Pharma, Inc. $ 159 - $ 0 -
Aldeyra Therapeutics, Inc. $ 120 - $ -20 -
Alimera Sciences Inc $ 85 $ 36 $ -25 -
Alkermes Plc. $ 7,722 $ 804 $ -196 -
Alnylam Pharmaceuticals, Inc. $ 9,714 $ 59 $ -414 -
Alexza Pharmaceuticals Inc. - - $ 0 -
Alexion Pharmaceuticals Inc $ 32,064 $ 3,412 $ 527 2,273
Amag Pharmaceuticals Inc. $ 648 $ 593 $ -45 -
Amylin Pharmaceuticals Inc - - $ 0 -
Ampio Pharmaceuticals, Inc. $ 36 - $ -12 -
Amphastar Pharmaceuticals, Inc. $ 788 $ 252 $ 9 -
Amarin Corp Plcuk $ 877 $ 151 $ -78 -
Anacor Pharmaceuticals, Inc. - - $ 0 -
Ani Pharmaceuticals Inc $ 594 $ 158 $ 5 -
Antriabio, Inc. $ 44 - $ -21 -
Anthera Pharmaceuticals Inc $ 14 - $ -43 -
Apricus Biosciences, Inc. $ 19 - $ 6 -
Aquinox Pharmaceuticals, Inc $ 320 - $ -41 -
Ardelyx, Inc. $ 256 - $ -166 -
Argos Therapeutics Inc $ 7 $ 1 $ -64 -
Aralez Pharmaceuticals Inc. $ 100 - $ 0 -
Arena Pharmaceuticals Inc $ 759 $ 118 $ -20 -
Arqule Inc $ 80 - $ -30 -
Array Biopharma Inc $ 1,957 $ 151 $ -117 -
Athersys, Inc $ 252 $ 3 $ 0 -
Actinium Pharmaceuticals, Inc. $ 34 - $ -28 -
Avenue Therapeutics, Inc. $ 19 - $ 0 -
Avadel Pharmaceuticals Plc $ 411 - $ 0 -
Aveo Pharmaceuticals Inc $ 283 $ 4 $ -28 -
Aoxing Pharmaceutical Company, Inc. $ 19 $ 30 $ -1 -
Axsome Therapeutics, Inc. $ 109 - $ 0 -
Biodelivery Sciences International Inc $ 155 $ 42 $ 0 -
Beigene, Ltd. $ 43,944 - $ 0 -
Dnib Unwind, Inc. - - $ 0 -
Biodel Inc - - $ 0 -
Bellicum Pharmaceuticals, Inc. $ 373 $ 1 $ -84 -
Bellerophon Therapeutics, Inc. $ 36 - $ -54 -
Biomarin Pharmaceutical Inc $ 16,290 $ 1,201 $ -175 -
Bristol Myers Squibb Co $ 103,365 $ 20,238 $ 4,561 25,000
Fitlife Brands, Inc. - - $ 0 -
Blueprint Medicines Corp $ 2,422 $ 26 $ -99 -
Biostar Pharmaceuticals, Inc. $ 4 - $ -6 -
Biospecifics Technologies Corp $ 340 $ 27 $ 12 -
Baxalta Inc - - $ 0 -
Beyondspring Inc. $ 785 - $ 0 -
Calithera Biosciences, Inc. $ 573 - $ -29 -
Catabasis Pharmaceuticals Inc $ 39 - $ -32 -
Cymabay Therapeutics, Inc. $ 217 - $ -27 -
Cambrex Corp $ 1,789 $ 517 $ 91 -
Columbia Laboratories Inc - - $ 0 -
Carbylan Therapeutics, Inc. - - $ 0 -
Chemocentryx, Inc. $ 347 $ 24 $ -32 -
Celgene Corp $ 116,682 $ 12,191 $ 2,602 6,012
Chembio Diagnostics, Inc. $ 75 $ 18 $ -8 -
Cempra, Inc. $ 163 $ 18 $ -99 -
Cerulean Pharma Inc. - - $ -39 -
Ceres Ventures, Inc. - - $ 0 -
Contrafect Corp $ 42 - $ -26 -
Chiasma, Inc $ 60 - $ -31 -
China Pharma Holdings, Inc. - - $ 0 -
Checkpoint Therapeutics, Inc. $ 192 - $ 0 -
Colucid Pharmaceuticals, Inc. - - $ 0 -
Cellectar Biosciences, Inc. $ 24 - $ -11 -
Clearside Biomedical, Inc. $ 206 $ 0 $ -19 -
Celsion Corp $ 10 $ 1 $ -22 -
Clovis Oncology, Inc. $ 3,476 - $ -370 -
Chimerix Inc $ 236 $ 4 $ -66 -
Conatus Pharmaceuticals Inc. $ 155 - $ -25 -
Concert Pharmaceuticals, Inc. $ 326 $ 0 $ 0 -
Coronado Biosciences Inc - - $ 0 -
Global Green Inc. - - $ 0 -
Collegium Pharmaceutical, Inc $ 296 $ 7 $ -98 -
Corium International, Inc. $ 341 $ 30 $ -44 -
Corcept Therapeutics Inc $ 2,154 $ 109 $ 24 -
China Pharma Holdings, Inc. $ 9 $ 15 $ -9 -
Cumberland Pharmaceuticals Inc $ 114 $ 35 $ -2 -
Catalyst Pharmaceuticals, Inc. $ 205 - $ -17 -
Corbus Pharmaceuticals Holdings, Inc. $ 329 $ 3 $ -28 -
Cormedix Inc. - - $ 0 -
Cardiome Pharma Corp - - $ 0 -
Crispr Therapeutics Ag - - $ 0 -
Corvus Pharmaceuticals, Inc. $ 327 - $ 0 -
Cti Biopharma Corp. $ 105 $ 37 $ -50 -
Catalent, Inc. $ 5,703 $ 2,075 $ 110 -
Contravir Pharmaceuticals, Inc. - - $ 0 -
Cyclacel Pharmaceuticals, Inc. $ 10 - $ -9 -
China Yct International Group, Inc. $ 12 $ 64 $ 12 -
Cymabay Therapeutics, Inc. - - $ 0 -
Cytokinetics Inc $ 685 $ 101 $ 0 -
Dara Biosciences, Inc. - - $ 0 -
Depomed Inc $ 370 $ 425 $ -111 -
Dermira, Inc. $ 1,104 $ 25 $ -101 -
Pronai Therapeutics Inc - - $ 0 -
Dipexium Pharmaceuticals, Inc. - - $ 0 -
Dicerna Pharmaceuticals Inc $ 94 $ 1 $ -58 -
Durect Corp $ 241 $ 16 $ -36 -
Dynavax Technologies Corp $ 1,034 $ 9 $ -101 -
Eleven Biotherapeutics, Inc. $ 40 $ 1 $ 3 -
Endocyte Inc $ 59 $ 0 $ -43 -
Egalet Corp $ 36 $ 23 $ -100 -
Eagle Pharmaceuticals, Inc. $ 928 $ 237 $ 105 -
Elite Pharmaceuticals Inc $ 96 $ 10 $ 25 -
Emisphere Technologies Inc $ 24 $ 1 $ -2 -
Endo International Plc $ 1,964 $ 1,691 $ -3,288 -
Enanta Pharmaceuticals Inc $ 837 $ 40 $ -21 -
Epirus Biopharmaceuticals, Inc. - - $ 0 -
Epizyme, Inc. $ 1,092 - $ -120 -
Esperion Therapeutics, Inc. $ 1,115 - $ -130 -
Evoke Pharma Inc $ 53 - $ -11 -
Eyegate Pharmaceuticals Inc $ 13 $ 1 $ -13 -
Fortress Biotech, Inc. $ 182 $ 64 $ -69 -
Fibrocell Science, Inc. $ 54 - $ -29 -
Fibrogen Inc $ 3,684 $ 118 $ -124 -
Flex Pharma, Inc. $ 62 $ 1 $ -36 -
Flamel Technologies Sa - - $ 0 -
Flexion Therapeutics Inc $ 849 - $ -94 -
Fresenius Medical Care Ag & Co. Kgaa - - $ 0 -
Antriabio, Inc. - - $ 0 -
Amicus Therapeutics Inc $ 2,257 $ 16 $ -208 -
Five Prime Therapeutics Inc $ 985 $ 36 $ -106 -
Fitlife Brands, Inc. $ 3 $ 25 $ 0 -
Futureworld Corp. - - $ 0 -
Galectin Therapeutics Inc $ 65 - $ -19 -
Globeimmune Inc - - $ 0 -
Gb Sciences Inc $ 29 - $ -10 -
Global Blood Therapeutics, Inc. $ 1,169 - $ -95 -
Gemphire Therapeutics Inc. $ 109 - $ 0 -
Geron Corp $ 347 $ 6 $ -28 -
Guardion Health Sciences, Inc. - - $ 0 -
Galmed Pharmaceuticals Ltd. $ 96 - $ 0 -
Glycomimetics Inc $ 383 - $ -51 -
Generex Biotechnology Corp $ 3 - $ -52 -
Genspera Inc - - $ 0 -
Genvec Inc $ 16 $ 0 $ -8 -
Global Green Inc. - - $ 0 -
Hutchison China Meditech Ltd $ 1,559 - $ 0 -
Heron Therapeutics, Inc. $ 766 - $ -190 -
HOSPIRA, INC. - - $ 0 -
Heat Biologics, Inc. $ 22 - $ -11 -
Horizon Pharma Plc $ 1,999 $ 1,029 $ -437 -
Imagenetix Inc - - $ 0 -
Ibio, Inc. $ 31 $ 0 $ -16 -
Intercept Pharmaceuticals Inc $ 1,845 $ 71 $ -385 -
Immune Design Corp. $ 265 $ 16 $ -53 -
Immunogen Inc $ 567 $ 89 $ -118 -
Imprimis Pharmaceuticals, Inc. $ 39 $ 24 $ -13 -
Immune Pharmaceuticals Inc $ 11 - $ -38 -
Immunocellular Therapeutics, Ltd. $ 1 - $ -21 -
Innocoll Holdings Plc $ 69 - $ 0 -
Insmed Inc $ 1,794 - $ -188 -
Insite Vision Inc - - $ 0 -
Insys Therapeutics, Inc. $ 640 $ 206 $ -6 -
Intellipharmaceutics International Inc. - - $ 0 -
Impax Laboratories Inc $ 1,709 $ 813 $ -578 -
Ironwood Pharmaceuticals Inc $ 2,309 $ 271 $ -143 -
Ionis Pharmaceuticals Inc - $ 486 $ 25 -
Intra-cellular Therapies, Inc. $ 836 $ 0 $ -102 -
Inotek Pharmaceuticals Corporation $ 41 - $ -41 -
Jaguar Health, Inc. $ 6 $ 2 $ -14 -
Jazz Pharmaceuticals Plc $ 9,083 $ 1,541 $ 404 -
Johnson & Johnson $ 360,233 $ 72,531 $ 16,500 126,500
Juniper Pharmaceuticals Inc $ 49 $ 58 $ 8 -
Kalobios Pharmaceuticals Inc - - $ 0 -
Kalvista Pharmaceuticals, Inc. $ 43 - $ 0 -
Humanigen, Inc $ 33 - $ -21 -
Kadmon Holdings, Inc. $ 184 - $ 0 -
Keryx Biopharmaceuticals Inc $ 779 $ 43 $ -185 -
Keyuan Petrochemicals, Inc. - - $ 0 -
Kindred Biosciences, Inc. $ 172 - $ -25 -
Kempharm, Inc $ 53 - $ -46 -
Karyopharm Therapeutics Inc. $ 480 $ 0 $ -112 -
China Shenghuo Pharmaceutical Holdings Inc - - $ 0 -
Kura Oncology, Inc. - - $ 0 -
Kythera Biopharmaceuticals Inc - - $ 0 -
Lannett Co Inc $ 640 $ 633 $ -1 -
Lifevantage Corp $ 59 $ 199 $ 2 -
Ligand Pharmaceuticals Inc $ 3,153 $ 117 $ 9 -
Lilly Eli & Co $ 88,374 $ 22,005 $ 2,447 39,135
Loxo Oncology, Inc. $ 2,387 - $ -100 -
Lipocine Inc. $ 80 - $ -17 -
Lexicon Pharmaceuticals, Inc. $ 1,349 $ 78 $ -144 -
Merrimack Pharmaceuticals Inc $ 1,946 - $ -145 -
Mabcure Inc. - - $ 0 -
Moleculin Biotech, Inc. $ 45 - $ -6 -
Seres Therapeutics, Inc. $ 677 $ 22 $ -97 -
Medicines Co $ 2,514 $ 106 $ -709 -
Medivation, Inc. - - $ 0 -
Mei Pharma, Inc. $ 201 $ 23 $ 3 -
Macrogenics Inc $ 604 $ 12 $ -147 -
Mmrglobal, Inc. - - $ 0 -
Mallinckrodt Plc $ 3,441 $ 3,183 $ 776 -
Mannkind Corp $ 194 $ 180 $ 129 -
Medicinova Inc $ 204 - $ -10 -
Merck & Co., Inc. $ 178,593 $ 40,015 $ 5,109 70,000
Marinus Pharmaceuticals Inc $ 96 - $ -22 -
Mirati Therapeutics, Inc. $ 258 - $ -75 -
Mast Therapeutics, Inc. - - $ 0 -
Mylan N.v. $ 16,655 $ 11,605 $ 533 25,000
Myos Rens Technology Inc. $ 8 $ 0 $ -4 -
Myovant Sciences Ltd. $ 730 - $ 0 -
Natures Sunshine Products Inc $ 202 $ 339 $ 8 -
Nabriva Therapeutics Plc $ 227 - $ 0 -
Novabay Pharmaceuticals, Inc. $ 69 $ 15 $ -11 -
Neos Therapeutics, Inc. $ 202 $ 16 $ -80 -
Neothetics, Inc. $ 5 - $ -10 -
Minerva Neurosciences, Inc. $ 252 - $ -38 -
China Nuokang Bio-pharmaceutical Inc. - - $ 0 -
Nektar Therapeutics $ 3,398 $ 133 $ -209 -
Newlink Genetics Corp $ 316 $ 41 $ -67 -
Novan, Inc. $ 88 - $ -21 -
Inergetics Inc - - $ 0 -
Nephrogenex, Inc. - - $ 0 -
Inspyr Therapeutics, Inc. - - $ 0 -
Neurotrope, Inc. $ 45 - $ -12 -
Nexvet Biopharma Plc $ 79 - $ -20 -
Novelion Therapeutics Inc. - - $ 0 -
Nivalis Therapeutics, Inc. $ 38 - $ -18 -
Novelos Therapeutics, Inc. - - $ 0 -
Northwest Biotherapeutics Inc $ 36 $ 0 $ -86 -
Northwest Biotherapeutics Inc - - $ 0 -
Ocera Therapeutics, Inc. $ 32 - $ -27 -
Ocular Therapeutix, Inc. $ 184 $ 2 $ -57 -
Oragenics Inc $ 18 - $ -8 -
Ohr Pharmaceutical Inc $ 41 - $ -25 -
Oncomed Pharmaceuticals Inc $ 166 $ 25 $ -86 -
Omeros Corp $ 924 $ 54 $ -63 -
Oncosec Medical Inc - - $ 0 -
Onconova Therapeutics, Inc. $ 16 $ 2 $ -18 -
Ophthotech Corp. $ 96 $ 10 $ -193 -
Opko Health, Inc. $ 3,656 $ 1,184 $ -77 -
Opexa Therapeutics, Inc. $ 7 - $ -5 -
Orexigen Therapeutics, Inc. $ 35 $ 63 $ -77 -
Oramed Pharmaceuticals Inc. $ 126 - $ 7 -
Oragenics Inc - - $ 0 -
Bioblast Pharma Ltd. - - $ 0 -
Otonomy, Inc. $ 104 $ 1 $ -104 -
Ovascience, Inc. $ 51 $ 0 $ -75 -
Phibro Animal Health Corp $ 1,421 $ 764 $ 65 -
Prestige Brands Holdings, Inc. $ 2,639 $ 929 $ 109 -
Puma Biotechnology, Inc. $ 3,877 - $ -289 -
Pacira Pharmaceuticals, Inc. $ 1,464 $ 281 $ -66 -
Aratana Therapeutics, Inc. $ 236 $ 47 $ -15 -
Pfizer Inc - - $ 0 78,300
Pfenex Inc. $ 73 $ 60 $ 4 -
Progenics Pharmaceuticals Inc $ 489 $ 64 $ -4 -
Pharmathene, Inc - $ 5 $ 114 -
Peak Pharmaceuticals, Inc. $ 2 - $ 0 -
Pozen Inc - - $ 0 -
Propanc Biopharma, Inc. - - $ -9 -
Peregrine Pharmaceuticals Inc $ 140 $ 79 $ -18 -
Perrigo Co Plc $ 12,186 $ 5,025 $ -2,947 -
Prophase Labs, Inc. $ 38 $ 15 $ 42 -
Prothena Corp Plc $ 2,477 $ 28 $ -145 -
Paratek Pharmaceuticals, Inc. $ 678 - $ -96 -
Protect Pharmaceutical Corp $ 1 - $ 0 -
Protalex Inc $ 26 - $ -5 -
Proto Script Pharmaceutical Corp $ 58 - $ 0 -
Ptc Therapeutics, Inc. $ 794 $ 123 $ -108 -
Patheon N.v. $ 5,116 - $ 0 -
Pain Therapeutics Inc - - $ 0 -
Portola Pharmaceuticals Inc $ 2,992 $ 32 $ -245 -
Palatin Technologies Inc $ 118 - $ -40 -
Pernix Therapeutics Holdings, Inc. $ 29 $ 142 $ -109 -
Provectus Biopharmaceuticals, Inc. $ 9 - $ -23 -
Phaserx, Inc. - - $ 0 -
Novelion Therapeutics Inc. - - $ 0 -
Uniqure N.v. $ 243 - $ 0 -
Ultragenyx Pharmaceutical Inc. $ 2,224 - $ -277 -
Ra Pharmaceuticals, Inc. $ 337 - $ 0 -
Rock Creek Pharmaceuticals, Inc. - - $ 0 5
Radius Health, Inc. $ 1,513 - $ -211 -
Regeneron Pharmaceuticals Inc $ 50,340 $ 5,236 $ 1,170 -
Reliv International Inc $ 13 $ 44 $ 0 -
Recro Pharma, Inc. $ 161 $ 70 $ -33 -
Reata Pharmaceuticals Inc $ 707 $ 51 $ -18 -
Regulus Therapeutics Inc. $ 70 $ 0 $ -81 -
Rigel Pharmaceuticals Inc $ 292 $ 19 $ -73 -
Relypsa Inc - - $ 0 -
Rexahn Pharmaceuticals, Inc. $ 68 - $ -24 -
Rosetta Genomics Ltd. - - $ 0 -
Raptor Pharmaceutical Corp - - $ 0 -
Retrophin, Inc. $ 889 $ 138 $ -70 -
Ritter Pharmaceuticals Inc $ 7 - $ -15 -
Revance Therapeutics, Inc. $ 725 $ 0 $ -99 -
Ignyta, Inc. $ 621 - $ -118 -
Rxi Pharmaceuticals Corp $ 11 - $ -13 -
Sage Therapeutics, Inc. $ 2,428 - $ -221 -
Spring Bank Pharmaceuticals, Inc. $ 148 - $ -22 -
Sciclone Pharmaceuticals Inc $ 594 $ 172 $ 43 -
Sucampo Pharmaceuticals, Inc. $ 547 $ 247 $ -153 -
Scynexis Inc $ 61 $ 0 $ -24 -
Sagent Pharmaceuticals, Inc. - - $ 0 -
Signpath Pharma, Inc. - - $ 0 -
Synergy Pharmaceuticals, Inc. $ 569 - $ -203 -
Shire Plc - $ 14,576 $ 652 -
Shire Plc - - $ 0 -
Siga Technologies Inc - - $ 0 -
Siga Technologies Inc - $ 6 $ -32 -
Sunset Island Group, Inc - - $ 0 -
Skystar Bio-pharmaceutical Co - - $ 0 -
Sibannac, Inc. $ 1 $ 0 $ 0 -
Sunesis Pharmaceuticals Inc $ 44 $ 3 $ -36 -
Madrigal Pharmaceuticals, Inc. - - $ -31 -
Sophiris Bio Inc. $ 68 $ 0 $ -7 -
Spectrum Pharmaceuticals Inc $ 771 $ 131 $ -85 -
Sarepta Therapeutics, Inc. $ 2,589 - $ -124 -
Sierra Oncology, Inc. $ 83 - $ 0 -
Steadymed Ltd. $ 82 $ 1 $ 39 -
Stemline Therapeutics Inc $ 258 $ 1 $ -50 -
Supernus Pharmaceuticals Inc $ 2,097 $ 253 $ 104 -
Sinovac Biotech Ltd - - $ 0 -
Savara Inc. $ 131 - $ 0 -
Growblox Sciences, Inc. - - $ 0 -
Synthetic Biologics, Inc. $ 118 - $ -18 -
Syros Pharmaceuticals, Inc. $ 396 - $ 0 -
Taro Pharmaceutical Industries Ltd - - $ 0 -
Theravance Biopharma, Inc. $ 1,729 $ 33 $ -214 -
Teva Pharmaceutical Industries Ltd $ 17,442 $ 22,723 $ 319 -
Threshold Pharmaceuticals Inc $ 39 - $ -13 -
Innoviva, Inc. - $ 176 $ 92 -
Tokai Pharmaceuticals Inc - - $ -30 -
Tetralogic Pharmaceuticals Corp - - $ 0 -
Tonix Pharmaceuticals Holding Corp. $ 31 - $ -25 -
Tianyin Pharmaceutical Co., Inc. - - $ 0 -
Tapimmune Inc. $ 26 - $ 0 -
Trevena Inc $ 146 - $ -107 -
Transcept Pharmaceuticals Inc - - $ 0 -
Tesaro, Inc. $ 6,406 $ 40 $ -527 -
Titan Pharmaceuticals Inc $ 34 $ 0 $ -11 -
Tetraphase Pharmaceuticals Inc $ 262 $ 5 $ -105 -
Therapeuticsmd, Inc. $ 1,267 $ 18 $ -89 -
Shineco, Inc. $ 71 - $ 0 -
United Therapeutics Corp $ 5,184 $ 1,632 $ 395 -
Vaccinogen Inc - - $ 0 -
Viking Therapeutics, Inc. $ 28 - $ -16 -
Vanda Pharmaceuticals Inc. $ 843 $ 156 $ -10 -
Vertex Pharmaceuticals Inc $ 38,264 $ 2,131 $ 269 -
Valeant Pharmaceuticals International, Inc. $ 4,982 $ 14,016 $ -1,139 -
Versartis, Inc. $ 763 - $ -118 -
Verastem, Inc. $ 179 - $ -46 -
Vitae Pharmaceuticals, Inc - - $ 0 -
Vital Therapies Inc $ 200 - $ -47 -
Vtv Therapeutics Inc. $ 56 $ 0 $ -55 -
Vivus Inc $ 102 $ 133 $ 33 -
World Health Energy Holdings, Inc. $ 45 - $ 0 -
Wuxi Pharmatech (cayman) Inc. - - $ 0 -
Xbiotech Inc. $ 155 - $ -47 -
Xenon Pharmaceuticals Inc. $ 52 $ 1 $ -29 -
Xencor Inc $ 1,035 $ 32 $ -39 -
Xenoport Inc - - $ 0 -
Xoma Corp $ 159 $ 12 $ -46 -
Zafgen, Inc. $ 91 - $ -53 -
Zogenix, Inc. $ 324 $ 27 $ -85 -
Zosano Pharma Corp $ 38 - $ -29 -
Zs Pharma, Inc. - - $ 0 -
Zoetis Inc. $ 31,735 $ 5,018 $ 877 -
Zynerba Pharmaceuticals, Inc. $ 83 - $ -11 -
Ovid Therapeutics Inc. $ 157 - $ 0 -
Shuttle Pharmaceuticals, Inc. - - $ 0 -
Major Pharmaceutical Preparations Industry $ 1,402,762 $ 302,096 $ 15,393 449,225
Earnings Earnings Earnings
Earnings Outlook increase
Looking into earnings estimates within the Major Pharmaceutical Preparations Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Major Pharmaceutical Preparations Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates.
Earnings Guidance unchanged
In the same quarter 22.22 % of companies, who provided earning outlook within Major Pharmaceutical Preparations Industry, have reiterated their earnings per share outlook for the current fiscal year unchanged.
Earnings Estimates decrease
Pessimism dominates within Major Pharmaceutical Preparations Industry, as most of the businesses cut their earnings guidance, staggering 44.44 % have revised down earnings outlook. Overall earnings expectations for the Major Pharmaceutical Preparations Industry were cut by %, to the annual earnings expectation of %.
Expected Eps Growth Eps Expectation Revision
n   %     Industry Expected EPS Growth
Total Ranking # Within Sector #
n   %   Industry Earnings Outlook Revision
Total Ranking # Within Sector #
Revenue Revenue Revenue
Sales Forecast increase
In the current quarter 33.33 % of companies, who have issued revenue expectation within Major Pharmaceutical Preparations Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year.
Sales Expectations unchanged
As even more corporations reiterate their sales projections, 66.67 % of businesses within Major Pharmaceutical Preparations Industry, while corporate executives do not expect any change of economic environment.
Sales Outlook decrease
In Major Pharmaceutical Preparations Industry, there were no sales guidance decreases
Expected Revenue Growth Revenue Expectation Revision
  %     Industry Expected Revenue Growth
Total Ranking # Within Sector #
  %   Industry Revenue Outlook Revision
Total Ranking # Within Sector #





Cardiovascular Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Arthritis & Pain Segment
Revenues Income
24.3% 7.73% - -
Y/Y Q/Q Y/Y Q/Q

Urology Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Oncology Segment
Revenues Income
9.97% 1.68% - -
Y/Y Q/Q Y/Y Q/Q

Endocrine Segment
Revenues Income
-34.8% -30.47% - -
Y/Y Q/Q Y/Y Q/Q

Economy

Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks

Event Calendar

RFIL's Report

RFIL's News

RFIL's Revenue Growth

RFIL's Description

Fundamentals

Charts & Quotes

RFIL's ROI

Suppliers

Competition

Customers & Markets

RFIL's Profitability

RFIL's Growth

Segment Results

RFIL's PE

RFIL's Dividends

RFIL's Quick Ratio

Screening


Share Price Performance

Growth Rates Ranking

Profitability

Valuation

Dividend

Financial Strength

Efficiency Ranking

Expectations

Mgmnt. Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com